查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1580929

芬苯达唑市场：按类型、按疾病类型、按销售管道、按应用、按最终用户 - 2025-2030 年全球预测

Fenbendazole Market by Type (Compound Formulations, Pure Substance), Disease Type (Cancer, Parasitic Infections), Sales Channel, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年芬苯达唑市值为8,1027万美元，预计到2024年将达到8,7469万美元，复合年增长率为8.11%，到2030年将达到139928万美元。

芬苯达唑是一种广谱驱虫药，主要用于兽药，属于苯并咪唑酮氨基甲酸酯类药物。它广泛用于治疗动物寄生虫感染疾病，如蛔虫、绦虫和其他胃肠道寄生虫。人们强调需要芬苯达唑来有效确保牲畜、宠物和其他动物的健康和生产力。该产品可以在兽医医院、畜牧业和农业经营中得到重要应用，在这些领域，维持牲畜的健康对于经济生存至关重要。它在人类中的应用也已出现，儘管有限，但有轶事证据和研究探索潜在的抗癌作用。

主要市场统计
基准年[2023] 81027万美元
预测年份 [2024] 87469万美元
预测年份 [2030] 1,399.28 百万美元
复合年增长率（%） 8.11%

芬苯达唑市场受到全球动物健康意识增强、寄生虫感染增加、兽医技术进步以及肉类和乳製品需求增加等因素的影响。人类製剂存在潜在的商机，但这需要大量的研究和监管导航。药物输送系统的创新也推动了成长，以提高功效和动物依从性。然而，市场扩张受到严格的法规环境、潜在副作用、替代抗寄生虫药物的竞争以及有关人类仿单标示外使用的伦理争论的限制。

强劲的研发投资带来了配方创新，并提高了生物有效性和治疗效率。目前的研究使我们能够探索效用，并研究已报导的人类可能的抗癌作用。市场竞争激烈，新的机会需要透过提高功效、安全性和成本效益来实现差异化。促进製药公司和研究机构之间的合作以确保遵守监管标准非常重要。应对这些挑战，同时加速探索新应用并推广其效益，将确保芬苯达唑的持续市场相关性和成长潜力。

市场动态：揭示快速发展的芬苯达唑市场的关键市场洞察

芬苯达唑市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加芬苯达唑在动物保健领域的核准和使用的监管支持政策
    • 全球宠物拥有率上升刺激了对广谱驱虫剂的需求
    • 集中畜牧业推动了对有效寄生虫控制解决方案的需求
  • 市场限制因素
    • 开发适合不同动物物种的芬苯达唑製剂的成本限制
  • 市场机会
    • 透过开发芬苯达唑联合疗法实现更全面的动物健康
    • 在野生动物管理计划中引入芬苯达唑以控制寄生虫传播
  • 市场挑战
    • 关于芬苯达唑对农业生态系残留影响的环境问题

波特的五力：驾驭芬苯达唑市场的策略工具

波特的五力架构是了解芬苯达唑市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解芬苯达唑市场的外部影响

外部宏观环境因素对芬苯达唑市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解芬苯达唑市场的竞争格局

对芬苯达唑市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵芬苯达唑市场供应商的绩效评估

FPNV定位矩阵是评估芬苯达唑市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了芬苯达唑市场的成功之路

芬苯达唑市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加强监管政策支持芬苯达唑在动物保健领域的核准和使用
      • 全球宠物拥有率不断上升刺激了广谱驱虫药的需求
      • 集中畜牧业增加了对有效寄生虫控制解决方案的需求
    • 抑制因素
      • 开发适合不同物种的芬苯达唑製剂的成本限制
    • 机会
      • 开发包括芬苯达唑在内的联合治疗方法，以涵盖更全面的动物健康
      • 将芬苯达唑引入野生动物管理计画以控制寄生虫传播
    • 任务
      • 关于芬苯达唑对农业生态系残留影响的环境问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章芬苯达唑市场：依类型

  • 复杂的准备工作
    • 粉末
    • 暂停
    • 药片
  • 纯物质

第七章芬苯达唑市场：依疾病类型

  • 癌症
    • 乳癌
    • 肺癌
    • 摄护腺癌
  • 寄生虫感染疾病
    • 胃肠道寄生虫
    • 肺线虫

第八章芬苯达唑市场：依销售管道

  • 直销
  • 经销商
  • 网路药房
  • 零售药房

第九章芬苯达唑市场：依应用分类

  • 製药
    • 动物用药品
    • 人类医学
  • 兽医学
    • 伴同性动物
      • 猫
      • 狗
    • 马
    • 家畜
      • 牛
      • 猪
      • 羊

第 10 章 芬苯达唑市场：依最终使用者分类

  • 动物农场
  • 製药公司
  • 调查机构
  • 兽医诊所

第十一章 芬苯达唑美洲市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区芬苯达唑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲芬苯达唑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准Safeguard 用于治疗野生鹌鹑胃肠道寄生虫
    • 默克以13亿美元收购Elanco的Aqua业务
    • Ceva 收购 Scout Bio 扩大生物製药业务
  • 战略分析和建议
    • 默克公司

公司名单

  • ADM Animal Nutrition
  • Alltech, Inc.
  • Blue Buffalo Pet Products, Inc.
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Huvepharma by Olon Spa
  • Kemin Industries, Inc.
  • Krka, dd, Novo mesto
  • Lasa Supergenerics Ltd.
  • Leo Bio-Care Pvt. Ltd.
  • Merck & Co., Inc.
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-1A1A064BFFCB

The Fenbendazole Market was valued at USD 810.27 million in 2023, expected to reach USD 874.69 million in 2024, and is projected to grow at a CAGR of 8.11%, to USD 1,399.28 million by 2030.

Fenbendazole, a broad-spectrum anthelmintic medication primarily used in veterinary medicine, falls under the class of benzimidazole carbamate drugs. It is extensively applied for managing parasitic infestations like roundworms, tapeworms, and other gastrointestinal parasites in animals. The necessity for fenbendazole is underscored by its efficacy in ensuring the health and productivity of livestock, pets, and other animals. The product finds significant application in veterinary clinics, animal husbandry, and farming operations where maintaining the health of livestock is paramount for economic viability. Human usage has also surfaced, although limited and often debated, in context with anecdotal evidence and research exploring potential anti-cancer properties.

KEY MARKET STATISTICS
Base Year [2023] USD 810.27 million
Estimated Year [2024] USD 874.69 million
Forecast Year [2030] USD 1,399.28 million
CAGR (%) 8.11%

The market for fenbendazole is influenced by factors such as increasing global awareness about animal health, rising incidences of parasitic infections, advancements in veterinary medicine, and heightened demand for meat and dairy products. There is a potential opportunity in human health formulations, but this requires substantial research and regulatory navigation. Growth is also driven by innovations in drug delivery systems for enhanced efficacy and animal compliance. However, market expansion is constrained by stringent regulatory environments, potential side effects, competition from alternative antiparasitic drugs, and ethical debates regarding off-label human use.

Investment in robust R&D can lead to innovations in fenbendazole formulations that enhance bioavailability and therapeutic efficiency. Current research could explore its utility in more precise treatments for specific parasitic species and investigate its reported anti-cancer potential in humans. The market exhibits a competitive landscape requiring differentiation through enhanced efficacy, safety profiles, and cost-effectiveness to capitalize on emerging opportunities. Promoting collaboration among pharmaceutical companies and research institutions, along with ensuring compliance with regulatory standards, is crucial. Addressing these challenges while expediting research on novel applications and extolling the benefits ensures sustained market relevance and growth potential for fenbendazole.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fenbendazole Market

The Fenbendazole Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
    • Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
    • Intensive livestock farming practices raising the necessity for effective parasitic control solutions
  • Market Restraints
    • Cost constraints in developing fenbendazole formulations suited for diverse species
  • Market Opportunities
    • Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
    • Introduction of fenbendazole in wildlife management programs to control parasite infestations
  • Market Challenges
    • Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems

Porter's Five Forces: A Strategic Tool for Navigating the Fenbendazole Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fenbendazole Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fenbendazole Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fenbendazole Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fenbendazole Market

A detailed market share analysis in the Fenbendazole Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fenbendazole Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fenbendazole Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fenbendazole Market

A strategic analysis of the Fenbendazole Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fenbendazole Market, highlighting leading vendors and their innovative profiles. These include ADM Animal Nutrition, Alltech, Inc., Blue Buffalo Pet Products, Inc., Boehringer Ingelheim Animal Health, Ceva Sante Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Huvepharma by Olon S.p.a., Kemin Industries, Inc., Krka, d. d., Novo mesto, Lasa Supergenerics Ltd., Leo Bio-Care Pvt. Ltd., Merck & Co., Inc., Nutreco N.V., Phibro Animal Health Corporation, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Fenbendazole Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Compound Formulations and Pure Substance. The Compound Formulations is further studied across Powder, Suspension, and Tablets.
  • Based on Disease Type, market is studied across Cancer and Parasitic Infections. The Cancer is further studied across Breast Cancer, Lung Cancer, and Prostate Cancer. The Parasitic Infections is further studied across Gastrointestinal Parasites and Lungworms.
  • Based on Sales Channel, market is studied across Direct Sales, Distributors, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, market is studied across Pharmaceutical and Veterinary Medicine. The Pharmaceutical is further studied across Animal Medicines and Human Medicines. The Veterinary Medicine is further studied across Companion Animals, Equine, and Livestock Animals. The Companion Animals is further studied across Cats and Dogs. The Livestock Animals is further studied across Cattle, Pigs, and Sheep.
  • Based on End User, market is studied across Animal Farms, Pharmaceutical Companies, Research Institutions, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
      • 5.1.1.2. Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
      • 5.1.1.3. Intensive livestock farming practices raising the necessity for effective parasitic control solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Cost constraints in developing fenbendazole formulations suited for diverse species
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
      • 5.1.3.2. Introduction of fenbendazole in wildlife management programs to control parasite infestations
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fenbendazole Market, by Type

  • 6.1. Introduction
  • 6.2. Compound Formulations
    • 6.2.1. Powder
    • 6.2.2. Suspension
    • 6.2.3. Tablets
  • 6.3. Pure Substance

7. Fenbendazole Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Cancer
    • 7.2.1. Breast Cancer
    • 7.2.2. Lung Cancer
    • 7.2.3. Prostate Cancer
  • 7.3. Parasitic Infections
    • 7.3.1. Gastrointestinal Parasites
    • 7.3.2. Lungworms

8. Fenbendazole Market, by Sales Channel

  • 8.1. Introduction
  • 8.2. Direct Sales
  • 8.3. Distributors
  • 8.4. Online Pharmacies
  • 8.5. Retail Pharmacies

9. Fenbendazole Market, by Application

  • 9.1. Introduction
  • 9.2. Pharmaceutical
    • 9.2.1. Animal Medicines
    • 9.2.2. Human Medicines
  • 9.3. Veterinary Medicine
    • 9.3.1. Companion Animals
      • 9.3.1.1. Cats
      • 9.3.1.2. Dogs
    • 9.3.2. Equine
    • 9.3.3. Livestock Animals
      • 9.3.3.1. Cattle
      • 9.3.3.2. Pigs
      • 9.3.3.3. Sheep

10. Fenbendazole Market, by End User

  • 10.1. Introduction
  • 10.2. Animal Farms
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Institutions
  • 10.5. Veterinary Clinics

11. Americas Fenbendazole Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Fenbendazole Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Fenbendazole Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. FDA approves Safe-Guard for treatment of GI worms in wild quail
    • 14.3.2. Merck acquires Elanco's Aqua business for USD 1.3 billion
    • 14.3.3. Ceva acquires Scout Bio to expand biotherapeutic initiatives
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Merck & Co., Inc.

Companies Mentioned

  • 1. ADM Animal Nutrition
  • 2. Alltech, Inc.
  • 3. Blue Buffalo Pet Products, Inc.
  • 4. Boehringer Ingelheim Animal Health
  • 5. Ceva Sante Animale
  • 6. Cipla Limited
  • 7. Dechra Pharmaceuticals PLC
  • 8. Elanco Animal Health Incorporated
  • 9. Evonik Industries AG
  • 10. Huvepharma by Olon S.p.a.
  • 11. Kemin Industries, Inc.
  • 12. Krka, d. d., Novo mesto
  • 13. Lasa Supergenerics Ltd.
  • 14. Leo Bio-Care Pvt. Ltd.
  • 15. Merck & Co., Inc.
  • 16. Nutreco N.V.
  • 17. Phibro Animal Health Corporation
  • 18. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • 19. Vetoquinol S.A.
  • 20. Virbac S.A.
  • 21. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. FENBENDAZOLE MARKET RESEARCH PROCESS
  • FIGURE 2. FENBENDAZOLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FENBENDAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FENBENDAZOLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FENBENDAZOLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FENBENDAZOLE MARKET DYNAMICS
  • TABLE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY PURE SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FENBENDAZOLE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FENBENDAZOLE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENBENDAZOLE MARKET SIZE, BY GASTROINTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNGWORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FENBENDAZOLE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FENBENDAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FENBENDAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FENBENDAZOLE MARKET SIZE, BY HUMAN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL FENBENDAZOLE MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL FENBENDAZOLE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL FENBENDAZOLE MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL FENBENDAZOLE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL FENBENDAZOLE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. FRANCE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 333. FRANCE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. FRANCE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 335. FRANCE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. GERMANY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 345. GERMANY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 346. GERMANY FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 347. GERMANY FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 348. GERMANY FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 349. GERMANY FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 355. ISRAEL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 357. ISRAEL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. ISRAEL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 359. ISRAEL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 360. ISRAEL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 361. ISRAEL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 367. ITALY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. ITALY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 369. ITALY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION